Skip to main content
Welcome
Faculty
Bursaries
Program
Registration
Accomodation
Venue
Contact
Program
Home
/
Program
2ND ADVANCED COURSE ON THE PHARMACOLOGICAL TREATMENT OF DRUG RESISTANT EPILEPSIES (DRE): FROM RARE TO COMMON EPILEPSIES
Day
- Any -
Friday, 8th November
Saturday, 9th November
Sunday, 10th November
Type
- Any -
Almuerzo
Sesiones
Talleres
Friday, 8th November
16:15
h -
16:30
h
Welcome and Introduction
Jose M Serratosa.
Madrid
Manuel Toledo Argany.
Barcelona
Torbjörn Tomson.
Stockholm
Bernhard J Steinhoff.
Kork
16:30
h -
17:00
h
Concept, Epidemiology and social impact of DRE
Eugen Trinka.
Salzburg
17:00
h -
17:30
h
Other impact of DRE: Mortality and SUDEP
Torbjörn Tomson.
Stockholm
17:30
h -
18:00
h
Pseudo-DRE: Concept and diagnosis
Torbjörn Tomson.
Stockholm
18:00
h -
19:00
h
Cases: Difficult to diagnose DRE
Chairman:
Manuel Toledo Argany
Jose M Serratosa.
Madrid
Torbjörn Tomson.
Stockholm
Bernhard J Steinhoff.
Kork
Saturday, 9th November
08:30
h -
09:00
h
Basic mechanisms
Heidrun Potschka.
Munich
09:00
h -
09:30
h
Can we predict DRE in the focal epilepsies?
Mar Carreño.
Barcelona
09:30
h -
10:00
h
Break
10:00
h -
10:30
h
Pharmacokinetic interactions between ASMs used in polytherapy
Cecilie Johannessen Landmark.
Oslo
10:30
h -
11:00
h
Rational polytherapy V.2024. Interactions of third generation ASMs
Andres M Kanner.
Miami
11:00
h -
11:30
h
Overtreatment vs therapeutic nihilism
Bernhard J Steinhoff.
Kork
11:30
h -
12:30
h
Cases: Polytherapy and interactions
Chairman:
Manuel Toledo Argany
Bernhard J Steinhoff.
Kork
Andres M Kanner.
Miami
Cecilie Johannessen Landmark.
Oslo
12:30
h -
13:00
h
Symposium 1- Jazz Pharmaceuticals
13:00
h -
14:00
h
Lunch
14:00
h -
14:30
h
ASMs close to launching and future strategies
Jacqueline French.
New York
14:30
h -
15:00
h
Advanced therapies
Jose M Serratosa.
Madrid
15:00
h -
15:30
h
How a patient lives DRE
Torie Robinson.
London
15:30
h -
16:00
h
Break
16:00
h -
16:30
h
Drug resistant IGEs: clinical characteristics
Javier Salas Puig.
Barcelona
16:30
h -
17:00
h
Treatment of drug resistant IGEs
Guido Rubboli.
Dianalund
17:00
h -
17:30
h
Symposium: Uncontrolled epilepsy: can we do better? (Sponsored by Angelini Pharma)
Sunday, 10th November
08:30
h -
09:00
h
Clinical characteristics of the main types of DEEs
Elena Gardella.
Dianalund
09:00
h -
09:30
h
Treatment of Dravet disease, Lennox-Gastaut syndrome, and other DEEs
Elena Gardella.
Dianalund
09:30
h -
10:30
h
Cases: DEEs
Chairman:
Manuel Toledo Argany
Elena Gardella.
Dianalund
10:30
h -
11:00
h
Break
11:00
h -
11:30
h
Symposium 3 - UCB Pharma
11:30
h -
12:15
h
Outcome measures in DRE clinical trials
Jacqueline French.
New York
12:15
h -
12:45
h
Comprehensive evaluation test
12:45
h -
13:00
h
Conclusions
Jose M Serratosa.
Madrid
Manuel Toledo Argany.
Barcelona
Torbjörn Tomson.
Stockholm
Bernhard J Steinhoff.
Kork